Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
RION CoTSE:6823 -1.57%91 Return-on-Tangible-Equity is 14.56% as of Mar. 2026, which is 53% above its 10-year median of 9.51. GuruFocus rates TSE:6823 with a GF Score™ of 91/100 and a GF Value™ of 円2,678.83 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 759 Medical Devices & Instruments companies, RION Co ranks better than 68.64% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. RION Co's annualized net income for the quarter that ended in Mar. 2026 was 円4,389 Mil. RION Co's average shareholder tangible equity for the quarter that ended in Mar. 2026 was 円30,137 Mil. Therefore, RION Co's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 14.56%.
The historical rank and industry rank for RION Co's Return-on-Tangible-Equity or its related term are showing as below:
TSE:6823'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 7.32 Med: 9.51 Max: 10.93
Current: 10.93
During the past 13 years, RION Co's highest Return-on-Tangible-Equity was 10.93%. The lowest was 7.32%. And the median was 9.51%.
TSE:6823's Return-on-Tangible-Equity is ranked better than 68.64% of 759
companies
in the Medical Devices & Instruments industry
Industry Median: 4.04
vs TSE:6823: 10.93
RION Co (TSE:6823) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
RION Co Return-on-Tangible-Equity Related Terms
RION Co Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for RION Co's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6823 vs ABT, SYK, MDT: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, RION Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RION Co Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, RION Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where RION Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 14.56% mean?
RION Co (TSE:6823) has a Return-on-Tangible-Equity of 14.56% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on RION Co and its competitors. This is 53% above median its historical median of 9.51. Over the past decade, RION Co's Return-on-Tangible-Equity has ranged from 7.32 to 10.93. According to the industry distribution chart, RION Co ranks #238 out of 759 companies in the Medical Devices & Instruments industry, placing it in the top 31.4%.
Is RION Co's Return-on-Tangible-Equity too high?
RION Co's current Return-on-Tangible-Equity of 14.56% is 53% above median its 10-year median of 9.51. Over the past 10 years, this metric has ranged from a low of 7.32 to a high of 10.93. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.04. RION Co's value of 14.56% is 260.4% above this industry median. Based on the distribution chart, RION Co ranks #238 out of 759 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, RION Co has a GF Score™ of 91/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does RION Co's Return-on-Tangible-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, RION Co ranks #238 out of 759 companies for Return-on-Tangible-Equity. This puts RION Co in the upper half of its industry. The industry median Return-on-Tangible-Equity is 4.04. RION Co's value of 14.56% is 260.4% above this benchmark. Historically, RION Co's own Return-on-Tangible-Equity has ranged from 7.32 to 10.93 over the past decade. While the company's 10-year median is 9.51 vs. the industry median of 4.04, RION Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.04, based on 759 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RION Co's current Return-on-Tangible-Equity of 14.56% is 260.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on RION Co and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RION Co's current Return-on-Tangible-Equity is 14.56%, which is 53% above median its own 10-year median of 9.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RION Co stock overvalued right now?
Based on GuruFocus' analysis, RION Co (TSE:6823) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,678.83, compared to a current price of 円3,440.00 — trading 28.4% above its estimated fair value. The current Return-on-Tangible-Equity is 14.56%, which is 53% above median its 10-year median of 9.51 and 260.4% above the Medical Devices & Instruments industry median of 4.04. RION Co's overall GF Score™ is 91/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For RION Co (TSE:6823), the current Return-on-Tangible-Equity is 14.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RION Co (TSE:6823) Overvalued in 2026?
Based on GuruFocus' analysis, RION Co stock appears to be overvalued.
The current stock price of 円3,440.00 is trading 28.4% above its estimated GF Value™ of 円2,678.83.
GuruFocus considers RION Co to be Modestly Overvalued.
Key valuation signals for TSE:6823:
Return-on-Tangible-Equity: 14.56% (53% above median its 10-year median of 9.51)
GF Value™: 円2,678.83 vs. price of 円3,440.00 (28.4% above fair value)
Industry Position: 260.4% above the Medical Devices & Instruments median (#238 of 759)
No single metric tells the full story. See the TSE:6823 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RION Co Ltd is engaged in manufacturing and selling of maintenance services of a medical device. The company offers hearing instruments and medical equipment, an environmental device including sound and vibration measuring instruments and particle counters and parts and equipment.
91GF Score
Get the complete analysis for TSE:6823
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6823 has been successfully added to your 
